Security key
81728A207
Faeth Therapeutics, Inc. - Common Stock, par value $0.0001 per share (FTH)
CUSIP: 81728A207
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 16,514
- Total 13F value
- $6,507
- Share change
- +16,514
- SEC-reported price per share
- $0.39
- Number of holders
- 1
- Value change
- +$6,507
- Number of buys
- 1
- Shares outstanding
- 25,898,756
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
1
Top holders
1
FTH full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Faeth Therapeutics, Inc. SEC filings
Faeth Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 81728A207
Recent filing periods:
Ownership snapshot
Top reported holders of FTH - Faeth Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Ikarian Capital, LLC
Disclosed value leader
Ikarian Capital, LLC
Comparable rows
0/15
Latest evidence
19 Feb 2025
13F
3/4/5
Highest disclosed value: $318,546
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Ikarian Capital, LLC has the largest disclosed position value at $318.5K.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Ikarian Capital, LLC's linked filing trail.
Disclosed position value
Top 5
Ikarian Capital, LLC
$318.5K
VANGUARD GROUP INC
$291.3K
Catalio Capital Management, LP
$144.3K
BOOTHBAY FUND MANAGEMENT, LLC
$84.7K
Robert Hamilton Pierce
$80.3K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Ikarian Capital, LLC |
13F
Company
|
—
class O/S missing
|
$318,546
649,963 shares
|
— | 31 Dec 2024 |
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$291,282
594,454 shares
|
— | 31 Dec 2024 |
| Catalio Capital Management, LP |
13F
Company
|
—
class O/S missing
|
$144,273
294,374 shares
|
— | 31 Dec 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$84,688
172,798 shares
|
— | 31 Dec 2024 |
| Robert Hamilton Pierce |
3/4/5
Chief R&D Officer
|
—
class O/S missing
|
$80,294
94,463 shares
|
— | 15 Feb 2022 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
—
class O/S missing
|
$76,848
156,800 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
16,514
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2026 Across Filers
Q1 2026 holders
30
Q1 2025 holders
1
Holder diff
-29
| Investor | Q1 2026 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend